Dana Ataya, MD

Cancer Focus:
Breast Cancer

Dr. Ataya is a board-certified, subspecialty-trained breast radiologist. She received her MD degree at the Northeastern Ohio Medical University. She completed her Diagnostic Radiology Residency and Breast Imaging Fellowship at the Cleveland Clinic, where she also served as Chief Resident. Her clinical practice involves interpreting mammograms, breast ultrasounds, breast MRI, and performing imaging guided breast procedures. Dr. Ataya has received several teaching awards and has been an invited speaker at local, regional, and national meetings. She is a co-investigator on two NIH/NCI R01 grants, including a grant seeking to identify radiomic and pathomic signatures to predict upstaging of ductal carcinoma in situ (DCIS). Dr. Ataya is also a Co-PI on a novel pilot study applying eco-evolutionary principles to treat HR+ HER2- metastatic breast cancer.   

Education & Training

Board Certification:

• Radiology - Diagnostic Radiology

Fellowship:

• Cleveland Clinic -

Residency:

• Cleveland Clinic -

Medical School:

• Northeastern Ohio Medical University - M.D.

• Byrd C, Kingsbury C, Niell B, Funaro K, Bhatt A, Weinfurtner RJ, Ataya D. Appropriateness of acute breast symptom recommendations provided by ChatGPT. Clin Imaging. 2025 Sep.125:110549. Pubmedid: 40540768.
• Weinfurtner RJ, Ataya D, Funaro K, Bhatt A, Abdalah M, Stringfield O, Raghunand N, Thompson Z, Lee MC, Czerniecki B, Muller AS, Soliman H, Han H. Quantitative habitat concentration analysis of triple negative breast cancer on MRI correlates with pathologic response to combination neoadjuvant immuno/chemotherapy. Clin Imaging. 2025 Nov.127:110618. Pubmedid: 40945432.
• Bhatt AA, Harper LK, Anderson S, Solanki MH, Ataya DK. Cystic Breast Disease: What to Do When It's Not So Cystic. J Breast Imaging. 2025 Mar.7(2):233-248. Pubmedid: 39809305.
• Mayfield JD, Ataya D, Abdalah M, Stringfield O, Bui MM, Raghunand N, Niell B, El Naqa I. Presurgical Upgrade Prediction of DCIS to Invasive Ductal Carcinoma Using Time-dependent Deep Learning Models with DCE MRI. Radiol Artif Intell. 2024 Sep.6(5):e230348. Pubmedid: 38900042. Pmcid: PMC11427917.
• Akker O, Ataya D. I saw the "breast within a breast" sign. Clin Imaging. 2024 Mar.107:110085. Pubmedid: 38262259.
• Washington I, Palm RF, White J, Rosenberg SA, Ataya D. The Role of MRI in Breast Cancer and Breast Conservation Therapy. Cancers (Basel). 2024 Jun.16(11). Pubmedid: 38893241. Pmcid: PMC11171236.
• Belfi LM, Slanetz PJ, Cooke EA, Chan S, Frederick-Dyer K, Ataya D, Choe AI, Deitte LA. Creativity, Connection, and Community: Reimagining the Radiology Society Meeting. Acad Radiol. 2024 Feb.31(2):351-359. Pubmedid: 38401980.
• Weinfurtner RJ, Abdalah M, Stringfield O, Ataya D, Williams A, Mooney B, Rosa M, Lee MC, Khakpour N, Laronga C, Czerniecki B, Diaz R, Ahmed K, Washington I, Latifi K, Niell B, Montejo M, Raghunand N. Quantitative Changes in Intratumoral Habitats on MRI Correlate With Pathologic Response in Early-stage ER/PR+ HER2− Breast Cancer Treated With Preoperative Stereotactic Ablative Body Radiotherapy. J Breast Imaging. 2022 May.4(3):273-284. Pubmedid: 36686407. Pmcid: PMC9851176.
• Weinfurtner RJ, Raghunand N, Stringfield O, Abdalah M, Niell BL, Ataya D, Williams A, Mooney B, Rosa M, Lee MC, Khakpour N, Laronga C, Czerniecki B, Diaz R, Ahmed K, Washington I, Montejo M. MRI Response to Pre-operative Stereotactic Ablative Body Radiotherapy (SABR) in Early Stage ER/PR+ HER2- Breast Cancer correlates with Surgical Pathology Tumor Bed Cellularity. Clin Breast Cancer. 2022 Feb.22(2):e214-e223. Pubmedid: 34384695.
• Niell BL, Abdalah M, Stringfield O, Raghunand N, Ataya D, Gillies R, Balagurunathan Y. Quantitative Measures of Background Parenchymal Enhancement Predict Breast Cancer Risk. Ajr Am J Roentgenol. 2021 Jul.217(1):64-75. Pubmedid: 32876474. Pmcid: PMC9801515.
• Parikh P, Jameel Z, Falcon S, Rosa M, Kiluk J, Hoover S, Soliman H, Ataya D. Adenomyoepithelioma of the breast: Case series and literature review. Clin Imaging. 2021 Jul.75:157-164. Pubmedid: 33607537.
• Funaro K, Ataya D, Niell B. Understanding the Mammography Audit. Radiol Clin North Am. 2021 Jan.59(1):41-55. Pubmedid: 33222999.
• Schwarz GS, Gatherwright J, Duraes EFR, Ataya D, Knackstedt R. Reply: Fat Grafting and the Palpable Breast Mass in Implant-Based Breast Reconstruction: Incidence and Implications. Plast Reconstr Surg. 2020 Apr.145(4):869e-870e. Pubmedid: 32221246.
• Ataya D, Niell BL. Complicated Cysts: Should Management Depend Upon Age?. Acad Radiol. 2019 Jul.26(7):907-908. Pubmedid: 30987873.
• Knackstedt RW, Gatherwright J, Ataya D, Duraes EFR, Schwarz GS. Fat Grafting and the Palpable Breast Mass in Implant-Based Breast Reconstruction: Incidence and Implications. Plast Reconstr Surg. 2019 Aug.144(2):265-275. Pubmedid: 31348325.
• Zhang G, Ataya D, L Lebda P, Calhoun BC. Mucocele-like lesions diagnosed on breast core biopsy: Low risk of upgrade and subsequent carcinoma. Breast J. 2018 May.24(3):314-318. Pubmedid: 29024198.
• Mosier A, Gupta E, Ataya D, Bhatt K, Rim A. Low Compliance in a Health-Conscience Spending Era Likely Helps Obviates the Need for 6 month BI-RADS 3 Breast MRI Follow-up After 1 year. Breast J. 2017 Sep.23(5):504-508. Pubmedid: 28248009.
• Sturgis CD, Ataya D, Calhoun BC, Velcheti V, Mukhopadhyay S. Breast Mass in a Woman with Recurrent Thymoma. Ann Am Thorac Soc. 2016 11.13(11):2097-2098. Pubmedid: 27831813.
• Ataya D, Chowdhry AA, Mohammed TL. Epipericardial fat pad necrosis: computed tomography findings and literature review. J Thorac Imaging. 2011 Nov.26(4):W140-W142. Pubmedid: 21135710.

• Title: Sequential first strike, second strike therapies on HR+ HER2- MBC
  Award Number: N/A
  Sponsor: FLORIDA BREAST CANCER
  Soyano M. (PD/PI), Ataya, D. (Co-PD/PI)